This inaugural course on genito-urinary cancer care is designed to equip healthcare professionals with the latest knowledge and skills in managing genito-urinary cancers. Participants delve into the multidisciplinary care approaches that involve collaboration among oncologists, urologists, radiologists, and other specialists to optimize patient outcomes. The course explores new treatment paradigms that are revolutionizing the field, providing insights into emerging therapies and innovative practices. Additionally, the pivotal role of precision medicine in the treatment of prostate and bladder cancers is highlighted, emphasizing how tailored treatments can enhance efficacy and minimize side effects. Join us to stay at the forefront of genito-urinary cancer care and make a meaningful impact on patient lives. Target Audience This course is designed for healthcare professional teams working in all areas of genito-urinary oncology practice. Learning Objectives Upon completion of this activity, participants should be able to: Evaluate current evidence guiding multimodal treatment strategies for advanced and localized genitourinary malignancies. Integrate emerging systemic therapies, including immunotherapies and targeted agents, into comprehensive GU cancer management. Differentiate clinical, molecular, and imaging biomarkers that inform prognosis and therapeutic selection in GU cancers. Formulate interdisciplinary approaches between urology, radiation oncology, and medical oncology to optimize oncologic and quality-of-life outcomes. Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.